Page 2 - Therapy Acceleration Program News Today

Investegate announcements from Faron Pharma. Oy, Proposed Issue and Placing

17.01.2023 - Strategic equity investment of USD 3 million to support clinical advancement of BI-1206 in Non-Hodgkins LymphomaSupports also clinical development of BI-1808 in cutaneous T-cell lymphomaLLS TAP is a strategic funding initiative to accelerate ... Seite 1

Strategic equity investment of USD 3 million to support clinical advancement of BI-1206 in Non-Hodgkin's LymphomaSupports also clinical development of BI-1808 in cutaneous T-cell lymphomaLLS TAP is a strategic

KRAKOW, Poland, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Ryvu Therapeutics [WSE:RVU], a clinical-stage drug discovery and development company focusing on novel...

/PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) recognized and celebrated the outstanding contributions of six LLS-funded scientific investigators for...

RYE BROOK, N.Y., Dec. 14, 2022 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) recognized and celebrated the outstanding contributions of si...

/PRNewswire/ -- At the 64th Annual American Society of Hematology (ASH) Annual Meeting (December 10-13), The Leukemia & Lymphoma Society (LLS) will be...

Significant round will enable the Company to advance ICT01, its lead anti-butyrophilin 3A antibody, to completion of randomized Phase II trialsSeries C...

Racial and ethnic minorities, rural residents, and people with lower socioeconomic status are overwhelmingly underrepresented in clinical trials. The...

(BPT) - Heather, of Yorba Linda, California, was diagnosed with a form of leukemia, acute myeloid leukemia (AML), in late 2017. One morning, when she woke up extremely pale and covered with bruises, she sought medical help to see what was wrong. After contacting her doctor, who ran her bloodwork and found her levels were significantly lower than average, she was rushed to the ER. “I was pretty near death at that time,” Heather said. It was after her ER visit that she found out she had...